Abstract
Regioselective synthesis, biological evaluation and 3D-molecular modeling for a series of novel diastereomeric 2-thioxo-5H-dispiro[imidazolidine-4,3-pyrrolidine-2,3-indole]-2,5(1H)-diones are described. The studied compounds have been tentatively identified as potent small molecule MDM2/p53 PPI inhibitors and can therefore be reasonably regarded as promising anticancer therapeutics.
Keywords:
3D molecular docking; Cell-based assay; Dispiro-indolinones; MDM2/p53; PPI inhibitors.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Publication types
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacology*
-
Cell Proliferation / drug effects*
-
Drug Design*
-
Humans
-
Models, Molecular
-
Molecular Dynamics Simulation
-
Molecular Structure
-
Neoplasms / drug therapy*
-
Neoplasms / pathology
-
Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors*
-
Small Molecule Libraries / chemical synthesis
-
Small Molecule Libraries / pharmacology
-
Structure-Activity Relationship
-
Tumor Cells, Cultured
-
Tumor Suppressor Protein p53 / antagonists & inhibitors*
Substances
-
Antineoplastic Agents
-
Small Molecule Libraries
-
TP53 protein, human
-
Tumor Suppressor Protein p53
-
MDM2 protein, human
-
Proto-Oncogene Proteins c-mdm2